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Members of the casein kinase 1 (CK1) family of ser-
ine/threonine kinases are highly conserved from yeast 
to mammals and are involved in the regulation of vari-
ous cellular processes. Specifically, the CK1 isoforms 
δ and ε have been shown to be involved in the regula-
tion of proliferative processes, differentiation, circadi-
an rhythm, as well as in the regulation of nuclear 
transport. In this report we show that CK1δ and ε inter-
act with murine RanBPM in the yeast two-hybrid sys-
tem (YTH) and that the putative CK1δ-interacting do-
mains of RanBPM are located between aa 155-386 and 
aa 515-653. Furthermore, in mammalian cells CK1δ 
partially co-localizes with RanBPM and can be co-
immunoprecipitated with RanBPM. In addition, CK1δ 
strongly phosphorylates RanBPM within aa 436-514 in 
vitro. The identification of the interacting and scaffold-
ing protein RanBPM as a new substrate of CK1δ 
points towards a possible function for CK1δ in modu-
lating RanBPM specific functions. 
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Introduction 
 
Members of the casein kinase 1 (CK1) family form a 
group of highly related, ubiquitously expressed serine/
threonine-specific kinases which can be found in all 
eukaryotic organisms (Knippschild et al. 2014, Ven-
erando et al. 2014). CK1 isoforms can be detected in 
the nucleus and cytoplasm, and are associated with 
cellular structures like the cytoskeleton, the centro-
somes, transport vesicles and the plasma membrane. 
Members of the CK1 family are able to phosphorylate 
a wide variety of substrates, suggesting an involve-
ment of CK1 in the regulation of various cellular pro-
cesses, including chromosome segregation, circadian 
rhythm, centrosome-specific functions, differentiation 
and apoptotic processes, and nuclear import processes 
(Cruciat 2014, Knippschild et al. 2014, Venerando et 
al. 2014). Furthermore, deregulation of CK1 expres-
sion and activity has been associated with several dis-
eases, among them neurodegenerative diseases 
(Flajolet et al. 2007, Hanger et al. 2007, Perez et al. 
2011, Rubio de la Torre et al. 2009) and cancer 
(Knippschild et al. 2014, Schittek & Sinnberg 2014). 
On protein level the activity of CK1 is modulated by 
several mechanisms, among them subcellular localiza-
tion, (auto-) phosphorylation, dephosphorylation, site-
specific cleavage by endoproteases, and interaction 
with cellular structures and proteins (Cruciat 2014, 
Knippschild et al. 2014). 
 The Ran Binding Protein in the Microtubule-
organizing center (MTOC), RanBPM, has first been 
described as a centrosomal protein with a molecular 
mass of 55 kDa (RanBPM55) (Nakamura et al. 1998). 
Later it was determined that RanBPM55 was a truncat-
ed variant of a 90 kDa protein (RanBP9) with both 
nuclear and cytoplasmic distribution (Nishitani et al. 
2001). The majority of Ran binding proteins (RanBPs) 
are related to the importin-β family of receptors, which 
regulate nuclear trafficking, and are regulated by the 
Ras-like nuclear small GTPase Ran (Murrin & Talbot 
2007). However, RanBPM lacks the consensus Ran-
binding domain (Beddow et al. 1995) and rather acts 
as an interaction partner for multiple receptors and as 
scaffolding protein for signal transduction components 
(Suresh et al. 2012). RanBPM contains several func-
tional domains, including a SPRY domain as well as 
LisH and CTLH motifs. The SPRY domain is involved 
in mediating several of the known protein–protein in-
teractions of RanBPM (Cheng et al. 2005, Hafizi et al. 
2005, Mikolajczyk et al. 2003, Rao et al. 2002, Wang 
et al. 2002a, Yuan et al. 2006), whereas the LisH and 
CTLH motifs are important for the regulation of     
homo-dimerization and binding to microtubules (Emes 
& Ponting 2001, Gerlitz et al. 2005, Mateja et al. 
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2006). 
 RanBPM interacts with a variety of receptors 
and signal transduction components, such as MET 
(Wang et al. 2002b), CDK11p46 (Mikolajczyk et al. 
2003), Mirk/Dyrk1B (Zou et al. 2003), Axl (Hafizi et 
al. 2002, 2005), and TrkA/B (Yin et al. 2010; Yuan et 
al. 2006). Furthermore, RanBPM acts as a scaffolding 
protein modulating downstream signaling of neural 
cell adhesion molecule L1 (Cheng et al. 2005), β2-
integrin LFA-1 (Denti et al. 2004), semaphorins 
(Togashi et al. 2006), and BM88/Cend1 (Tsioras et al. 
2013). By interacting with p73α, RanBPM seems to 
enhance the pro-apoptotic activity of p73α, by prevent-
ing its degradation via the ubiquitin proteasome path-
way (Kramer et al. 2005). In addition, RanBPM has 
been shown to exhibit enhancing effects on amyloid β 
peptide generation in Alzheimer’s disease by scaffold-
ing APP (amyloid precursor protein), BACE1 and LRP 
(lipoprotein receptor-related protein) (Lakshmana et al. 
2008, 2009, 2010, 2012). Moreover, RanBPM interacts 
with HDAC6, a component of the aggresome complex. 
There is increasing evidence that RanBPM promotes 
aggresome formation since silencing of RanBPM im-
pairs aggresome formation (Salemi et al. 2014). 
 In the present study we identified RanBPM as 
an interaction partner of CK1 family members in the 
yeast two-hybrid (YTH) system, especially of CK1δ 
and ε. The putative CK1δ-interacting domains of 
RanBPM are located between aa 155-386 and aa 515-
653. Furthermore, RanBPM co-immunoprecipitates 
with CK1δ, and is phosphorylated by CK1δ at several 
amino acids within aa 436-514 in vitro. These findings 
point towards a possible function for CK1δ in regulat-
ing RanBPM specific functions. 
 
          Materials and methods 
 
Expression vectors 
Construction of the bait plasmids 
pGBKT7-wt-CK1δ and pGBKT7-mt-
CK1δ has been described previously 
(Wolff et al. 2005). pGBKT7-CK1α, 
pGBKT7-CK1γ3 and pGBKT7-CK1ε 
were kindly provided by Dr. David 
Meek, Dundee, Scotland (Sillibourne et 
al. 2002). Primers listed in Table 1 were 
used to amplify cDNAs of several frag-
ments of murine RanBPM55  from a 
GAL4 Matchmaker mouse testis library 
in pACT2 (Clontech, Takara Bio Inc., 
USA). PCR products were ligated into 
pcDNA3.1/V5-His©-TOPO® 
(Invitrogen, USA) and subcloned into 
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Primer Sequence RanBP9 Sequence 
5’RanBPM-1 
5´-TCTCGAGACCCGGGTATGGGAATTGGTCTTT-3´ 
(5´ RanBP9, XhoI/XmaI) 
nt 463-478 
5’RanBPM-2 
5´-TCTCGAGACCCGGGTATGTTTGTGTTTGATAT-3´ 
(5´ RanBP9, XhoI/XmaI) 
nt 775-788 
5’RanBPM-3 
5´-TCTCGAGACCCGGGTATGCGGTGTTTGGGA-3´ 
(5´ RanBP9, XhoI/XmaI) 
nt 1156-1167 
5’RanBPM-4 
5´-TCTCGAGACCCGGGTATGGAAAGTTGTAGC-3´ 
(5´ RanBP9, XhoI/XmaI) 
nt 1306-1317 
5’RanBPM-5 
5´-TCTCGAGACCCGGGTATGGAAGATTGTGAC-3´ 
(5´ RanBP9, XhoI/XmaI) 
nt 1543-1557 
3’RanBPM-6 
5´-TCTCGAGGGTACCTAAGGATGTTGCCCAAA-3´ 
(3´ RanBP9, XhoI/KpnI) 
nt 760-774 
3’RanBPM-7 
5´-TCTCGAGGGTACCTACACTTCACTGTCTGT-3´ 
(3´ RanBP9, XhoI/KpnI) 
nt 1141-1155 
3’RanBPM-8 
5´-TCTCGAGGGTACCTATACACCATTGCTACAAC-3´ 
(3´ RanBP9, XhoI/KpnI) 
nt 1310-1326 
3’RanBPM-9 
5´-TCTCGAGGGTACCTATTCGTGGTCATGTTTAG-3´ 
(3´ RanBP9, XhoI/KpnI) 
nt 1526-1542 
3’RanBPM-10 
5´-TCTCGAGGGTACCTAATGTAGGTAGTCTTCC-3´ 
(3´ RanBP9, XhoI/KpnI) 
nt 1944-1959 
Primer pair 
bp 
RanBP9 
aa 
RanBP9 
Vector names 
Fusion 
Protein (FP) 
5’RanBPM-1 / 
3’RanBPM-10 
1497 155-653 
pcDNA3.1-RanBPM 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 974 
FP 980 
FP 986 
5’RanBPM-1 / 
3’RanBPM-6 
312 155-258 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 969 
FP 975 
5’RanBPM-2 / 
3’RanBPM-7 
381 259-385 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 970 
FP 976 
5’RanBPM-3 / 
3’RanBPM-8 
171 386-442 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 971 
FP 977 
5’RanBPM-4 / 
3’RanBPM-9 
237 436-514 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 972 
FP 978 
5’RanBPM-5 / 
3’RanBPM-10 
417 515-653 
pGADT7-RanBPM 
pGEX-RanBPM 
FP 973 
FP 979 
Table 1. Sequences of RanBPM55-specific primers (RanBPM, a 55 kDa protein, the nucleotide position refers to the sequence 
of the murine RanBP9 NM_019930.2) (nt: nucleotide). 
Table 2. Generation of murine RanBPM55 expression vectors (bp: base pair; 
aa: amino acid). 
 
pGADT7, pEYFP-C1 (both Clontech, Takara Bio Inc., 
USA) and pGEX-4T-3 (GE Healthcare, USA) (Table 
2). 
 
Yeast two-hybrid assay 
To screen for novel CK1δ interacting proteins, yeast 
two-hybrid analyses were carried out as described pre-
viously (Wolff et al. 2005). The yeast strain AH109 
was co-transformed with pGBKT7-CK1δ and the 
mouse testis library in pACT2 (Clontech, Takara Bio 
Inc, USA). To eliminate auto-activating library plas-
mids or plasmids containing proteins, which interacted 
with the GAL4 DNA binding domain, library plasmids 
isolated from positive yeast clones were co-
transformed with pGBKT7 into AH109. False positive 
library plasmids were identified after co-
transformation with pAS2-LaminC. The cDNA inserts 
of true positive plasmids were sequenced. 
 
Cell culture and transfection of cells 
MiaPaCa2 (Yunis et al. 1977), HeLa (Gey, 1952), and 
CV1 cells (Manteuil et al. 1973) were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) 
whereas BxPC3 cells (Loor et al. 1982) were main-
tained in a 1:1 mixture of DMEM and Roswell Park 
Memorial Institute medium (RPMI). All media con-
tained 10% heat-inactivated fetal calf serum (FCS) 
(Gibco, USA), 100 units/mL penicillin, 100 μg/mL 
streptomycin (Gibco, Germany), and 2 mM glutamine. 
Cell cultures were incubated at 37°C in a humidified 
5% (v/v) CO2 atmosphere. Cell lines HeLa and CV1 
were transfected with the plasmid pEYFP-C1-
RanBPM55. Transient transfections were performed 
using subconfluent cultures in 10-cm dishes or six-well 
tissue culture plates using Effectene Transfection Rea-
gent (Qiagen, Germany) according to the manufactur-
er’s instructions. 
 
Antibodies and immunocytochemistry 
The peptide GFLNCSSKHDHEMED (aa 579 - 593 of 
human or aa 503 - 517 of murine RanBP9, respective-
ly) was coupled to KLH, emulsified in TiterMax Gold 
(Sigma-Aldrich, Germany) and used for subsequent 
subcutaneous injections of rabbits. After three to four 
boosts the animals were bled out. Depletion experi-
ments using the RanBPM-specific peptide for preincu-
bation with the RanBPM-specific serum clearly 
demonstrated the specificity of the anti-RanBPM se-
rum. 
 To determine the subcellular localization of 
CK1δ in HeLa and CV1 cells, the monoclonal mouse 
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Figure 1. RanBPM sequence aligments on protein level. 
Comparison of the amino acid sequence of the cDNA se-
quence cloned into pVII16 with the amino acid sequence of 
murine RanBPM (gi: 161353515, accession number 
NP_064314.2). 
Figure 2. Interaction of CK1 isoforms and RanBPM. Vector pVII16 expressing RanBPM55 was cotransformed with pGBKT7-
CK1α, pGBKT7-CK1γ3, pGBKT7-CK1ε pGBKT7-CK1δrev or pGBKT7-CK1δwt into the yeast strain AH109. Positive clones 
were selected by growing the transformed yeast first on SD/-Trp/-Leu/-His plates (LTH) followed by platting onto more strin-
gent SD/-Trp/-Leu/-His/-Ade plates (LTHA) The ability of the transformants to grow was analyzed.  
anti-CK1δ antibody 128A (ICOS Corporation, now 
Lilly, USA) was used. An Alexa 568-conjugated anti-
mouse antibody (MoBiTec GmbH, Germany) was 
used as fluorophore-labeled secondary antibody. Cells 
were fixed and permeabilized with ice-cold methanol. 
Stained cells were analyzed using an epifluorescence 
microscope (IX70 Olympus, Germany). 
 
Cell lysis, immunoprecipitation, SDS-PAGE, West-
ern blotting, and IP-Western analysis 
Cellular lysates were obtained as described previously 
(Wolff et al. 2005). Cleared extracts were subjected to 
immunoprecipitation using RanBPM-specific serum 
(CGV1) and protein A sepharose beads (PAS) (GE 
Healthcare, USA). Negative controls were done using 
mouse IgG (Jackson ImmunoResearch Europe Ltd., 
UK). Immunoprecipitates were analyzed as described 
before (Wolff et al. 2005). For IP-Western experi-
ments, the endogenous RanBPM was detected in 
BxPC3 and MiaPaCa2 cells by using the RanBPM 
specific rabbit serum (CGV1). After immunoprecipita-
tion of RanBPM, the precipitates were separated by 
SDS-PAGE and transfered to nitrocellulose mem-
branes. The detection of CK1δ in the immune complex 
was performed using the antibody 128A (ICOS Corpo-
ration, now Lilly, USA). 
 
 
Expression and purification of recombinant pro-
teins 
Expression and purification of GST-RanBPM55 fusion 
proteins was done as described previously 
(Knippschild et al. 1997). In vitro transcription/
translation of His-RanBPM55 was done using TNT 
reticulocyte extract (Promega, USA) according to the 
manufacturer’s instructions. 
 
In vitro kinase assays 
In vitro kinase assays were carried out as described 
previously (Knippschild et al. 1996, Wolff et al. 2005) 
using His-RanBPM55 or GST-RanBPM55 fusion pro-
teins (expressed from pGEX-4T-3) encoded by the 
pGEX-vectors shown in Table 2. Reactions were start-
ed by adding CK1δ kinase domain (CK1δKD; NEB, 
USA) as enzyme and incubated at 30°C for 30 min or 
as indicated. Phosphorylated proteins were separated 
by SDS-PAGE and detected by autoradiography. 
 
Results 
 
CK1 isoforms interact with RanBPM55 
In order to identify new protein interaction partners for 
CK1δ, a cDNA library from mouse testis was screened 
for interactions with the mutant CK1δ variant CK1δrev 
(Hirner et al. 2012) as bait in a yeast-two-hybrid 
(YTH) screen. Variant CK1δrev was chosen for the 
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Figure 3. Interaction of CK1δ and RanBPM. (A) Schematic representation of the RanBPM55 fragments. (B) The vectors with 
RanBPM fragments were cotransformed with pGBKT7-CK1δ rev into the yeast strain AH109. Positive clones were selected by 
growing the transformed yeast first on SD/-Trp/-Leu/-His plates (LTH) followed by platting onto more stringent                     
SD/-Trp/-Leu/-His/-Ade plates (LTHA). The ability of the transformants to grow was analyzed. 
initial experiments since this mutant only exhibits one 
third of the kinase activity of wt CK1δ and therefore 
its overexpression does not cause the same cytotoxic 
effects which can be observed for overexpression of wt 
CK1δ. 
 Transformed yeast cells were selected on   
semi-stringent SD/-Trp/-Leu/-His (LTH) plates, fol-
lowed by re-platting positive colonies onto              
SD/-Trp/-Leu/-His/-Ade (LTHA) plates for a more 
stringent selection. From one positive clone the plas-
mid termed pVII16 was isolated containing a N-
terminally truncated sequence of murine RanBPM 
(Figure 1). pVII16 together with either pGBKT7-
CK1α, pGBKT7-CK1γ3, pGBKT7-CK1ε, pGBKT7-
rev-CK1δ, or pGBKT7-CK1δwt, were cotransformed 
into AH109 to analyze its interaction with the different 
CK1 isoforms in the YTH system. Cells cotransformed 
with RanBPM/CK1δrev, RanBPM/CK1δwt, and 
RanBPM/CK1ε exhibited growth on SC/-Leu/-Trp/-
His/-Ade medium. RanBPM/CK1α, RanBPM/CK1γ3 
showed only partial growth on more stringent medium 
(Figure 2). The specificity of the interaction of 
RanBPM with the indicated CK1 isoforms was con-
firmed by the inability of RanBPM to interact with 
Gal4 DBD or GAL4 DBD-lamin C (data not shown). 
For further studies the full-length sequence of murine 
RanBPM55, a N-terminally truncated form of RanBP9 
(accession ID AAD01272.1), was amplified from the 
mouse testis cDNA library. 
 
 
Identification of CK1δ and RanBPM55 interaction 
domains 
Fragments of RanBPM55 were generated (Figure 3a) 
and used in the YTH system in order to identify the 
CK1δ domain(s) necessary for the interaction with 
RanBPM55. On LTH plates (Figure 3b), fragment 
GAL4 AD-RanBPM259-385 could mediate an interaction 
with CK1δ as strongly as full length RanBPM55 
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Figure 4. Subcellular localization of CK1δ and EYFP-RanBPM55 in CV1 and HeLa cell lines. Two days after transfection CV1 
cells and HeLa cells were fixed with ice-cold methanol and permeabilized. (A) and (D) show EYFP-RanBPM55. In panels (B) 
and (E), CK1δ was labeled with the antibody 128A and an Alexa 568-conjugated secondary antibody. In the superposition of 
the fluorescence channels shown in panels (C) and (F), co-localization of RanBPM55 and CK1δ appears as a yellow color. 
Figure 5. CK1δ co-immunoprecipitates with RanBPM. (A) 
Detection of RanBPM in cellular lysates of BxPC3 and Mi-
aPaCa2 cells were separated by SDS-PAGE and transferred 
to a nitrocellulose membrane. The detection of RanBPM in 
Western blot analysis was performed using the polyclonal 
rabbit serum CGV1 (lane A1: BxPC3, anti-RanBPM; lane 
A2: MiaPaCa2, anti-RanBPM). (B) RanBPM was immuno-
precipitated from BxPC3 cells and MiaPaCa-2 cells using 
an anti-RanBPM antibody. The detection of CK1δ in the 
immune complex was performed using the antibody 128A. 
(lane B1: BxPC3, IP against RanBPM; lane B2: MiaPaCa2, 
IP against RanBPM). 
(GAL4 AD-RanBPM155-653). Fragments including aa 
155-258, aa 386-442 and aa 515-653 of RanBPM55 
also showed interaction whereas GAL4 AD-
RanBPM436-514 only showed a weak interaction with 
CK1δ. All described interactions were not observed 
using more stringent SD/-Trp/-Leu/-His/-Ade medium 
(LTHA). 
 
Characterization of the interaction between 
RanBPM and CK1δ in mammalian cells 
Additional cell biological and biochemical analyses 
were performed to confirm the physiological relevance 
of the interaction between RanBPM and CK1δ detect-
ed in the YTH system. First, analysis of the subcellular 
localization of CK1δ and RanBPM55 in HeLa and 
CV1 cells transfected with the plasmid pEYFP-C1-
RanBPM55 by immunofluorescence microscopy, us-
ing the CK1δ-specific antibody 128A, revealed a par-
tial co-localization of both proteins in the perinuclear 
area (Figure 4). Secondly, IP-Western-analysis re-
vealed that CK1δ co-immunoprecipitates with 
RanBPM in cellular lysates of BxPC3 and MiaPaCa2 
cells (Figure 5).  
 
RanBPM55 is phosphorylated by CK1δ in vitro  
Since sequence based analysis of RanBPM55 identi-
fied several serine and threonine residues as putative 
targets for CK1 mediated phosphorylation, in vitro 
kinase assays were performed to verify RanBPM55 
phosphorylation by CK1. His-tagged RanBPM55, in 
vitro translated from pcDNA3.1-RanBPM (His-
RanBPM155-653), was phosphorylated using C-
terminally truncated CK1δ (CK1δKD). The appear-
ance of a phosphorylated band at around 55 kDa indi-
cated that CK1δ can phosphorylate RanBPM55 in 
vitro (Figure 6a). No phosphate incorporation into the 
substrate was detected for control reactions performed 
without kinase (data not shown). 
 In order to localize the phosphorylation sites 
targeted by CK1δ, different GST-RanBPM55 frag-
ments were purified and same protein amounts of these 
were used as substrates for in vitro kinase assays. As 
shown in Figure 6b CK1δKD differently phosphory-
lated the different GST-RanBPM fusion proteins. 
Highest phosphate incorporation was detected for the 
GST-RanBPM436-514 protein pointing to the existence 
of one or more major phosphorylation sites in the re-
spective region. GST-RanBPM515-653 as well as GST-
RanBPM259-385 showed significantly weaker phos-
phorylation intensity. Nearly all GST-RanBPM fusion 
proteins showed different degrees of degradation after 
the performed purification steps, especially GST-
RanBPM259-385 and GST-RanBPM515-653 were highly 
degraded, and most phosphate incorporation could be 
detected in degradation products. 
 
Discussion 
 
CK1δ, a member of the CK1 family, plays an im-
portant role in the regulation of various cellular pro-
cesses including circadian rhythm, vesicle transport, 
chromosome segregation, and centrosome specific 
functions. Therefore, CK1δ has to be tightly regulated 
by several mechanisms, including interaction with cel-
lular structures and proteins (reviewed by Knippschild 
et al. 2014). However, little is known about protein-
protein interactions which may influence activity or 
localization of CK1 isoforms. In the present study we 
identified RanBPM as a new interaction partner for 
CK1 isoforms α, γ3, δ, and ε in the yeast two-hybrid 
system. However, interaction of RanBPM with CK1δ 
and ε was significantly stronger compared to those 
with CK1α and γ3. Using different RanBPM fragments 
the domain responsible for mediating the interaction 
with CK1δ could be located between aa 259-385. This 
region is located directly N-terminal to the SPRY do-
main (aa 212–333) of RanBPM, which has been shown 
to mediate most of the so far reported protein-protein 
interactions (Ponting et al. 1997). In subsequent exper-
imental approaches, we were able to confirm the inter-
action of RanBPM and CK1δ using mammalian cell 
lines. Whereas our immunofluorescence analyses only 
revealed a partial co-localization in the perinuclear 
region, our IP-Western analyses clearly showed that 
CK1δ co-immunoprecipitates with RanBPM. The par-
tial co-localization of both proteins could be explained 
by the fact that RanBPM is predominantly localized in 
chromatin-free areas, the so-called nuclear speckles 
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Figure 6. In vitro phosphorylation of RanBPM by CK1δ. (A) In vitro kinase assays were performed using His-RanBPM55 as 
substrate and C-terminally truncated CK1δ. Proteins were separated in SDS-PAGE, stained with Coomassie staining solution 
(C), and the phosphorylation was detected by autoradiography (A). (B) In vitro kinase assays were performed using GST-
RanBPM55 fragments (described in Figure 1) as substrate and C-terminally truncated CK1δ. The proteins were separated in 
SDS-PAGE, stained with Coomassie staining solution (C), and the phosphorylation was detected by autoradiography (A). 
(Lamond & Spector 2003) in association with various 
proteins (Ideguchi et al. 2002, Mikolajczyk et al. 2003, 
Rao et al. 2002, Wang et al. 2002b, Zou et al. 2003), 
whereas CK1δ can be mainly detected in the perinucle-
ar region in association with membrane structures, 
transport vesicles, microtubules, and centrosomes 
(reviewed by Knippschild et al. 2014). However, in 
some cases it has been reported that RanBPM is locat-
ed in the cytoplasm thereby interacting with various 
cellular structures and the plasma membrane (Lamond 
& Spector 2003). RanBPM often acts as scaffold pro-
tein containing a LisH/CTLH motif, which is present 
in proteins involved in microtubule dynamics, cell mi-
gration, nucleokinesis, and chromosome segregation 
(Kobayashi et al. 2007). By phosphorylation CK1δ 
might regulate these functions of RanBPM. CK1δ ac-
tually is able to phosphorylate RanBPM in vitro espe-
cially between aa 436-514. Interestingly, this strongly 
phosphorylated RanBPM fragment exhibits the weak-
est interaction with CK1δ as determined by YTH as-
says. This fact indicates, that binding of RanBPM55 to 
CK1δ is mediated by a certain domain (i.e. aa 259-
385) which is not identical to the domain which ap-
pears to be the main target for CK1δ-mediated phos-
phorylation (aa 436-514). RanBPM has been reported 
to be phosphorylated by several kinases, including 
CDK11p46, Plk (Mikolajczyk et al. 2003), Dyrk1B 
(Tsioras et al. 2013), PKC gamma/delta (Rex et al. 
2010), and p38 (Denti et al. 2004) pointing to an im-
portant role of site-specific phosphorylation in regulat-
ing RanBPM-specific functions as well as its subcellu-
lar localization (Suresh et al. 2012). However, addi-
tional experiments have to be set up to identify the 
amino acids of RanBPM targeted by CK1δ and to 
identify the physiological consequences of CK1δ-
mediated site-specific phosphorylation on RanBPM 
cellular functions.  
 In summary, RanBPM has been identified as a 
new interaction partner of CK1δ. The specificity of the 
biological relevance is underlined by the following 
facts: (i) RanBPM specifically interacts with various 
CK1 isoforms, namely with CK1α, γ3, δ, and ε, (ii) 
RanBPM is phosphorylated by CK1δ in vitro, and (iii) 
RanBPM interacts with CK1δ in pancreatic tumor cell 
lines, as confirmed by IP-Western analysis. However, 
additional analysis is required to evaluate the physio-
logical relevance of the interaction between CK1δ and 
RanBPM in detail. 
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